Immuron IMRN
NASDAQ IMRN
$1.25 +0.01 (+1.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Total Non-Current Liabilities (2017 - 2026)

Immuron (IMRN) posted Total Non-Current Liabilities of $201147.0 for Q3 2026, up 112.68% on a QoQ basis from $94577.0 in Q4 2025, and up 21168.07% year-over-year from N/an in Q3 2025.

Analysis

Immuron (IMRN) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends

Immuron has reported Total Non-Current Liabilities for 10 years, with the latest figure at $201147.0 in Q3 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 21168.07% year-over-year to $201147.0 in Q3 2026; TTM through Aug 2026 was $201147.0, a 21168.07% increase from a year earlier, with the FY2026 full-year figure at $201147.0, up 21168.07% from the prior year.
  • Total Non-Current Liabilities was $201147.0 for Q3 2026 at Immuron, up from $94577.0 in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $201147.0 in Q3 2026, with the low at $943.17 in Q3 2024.
  • Average Total Non-Current Liabilities over 5 years is $86363.2, with a median of $96831.2 recorded in 2025.
  • The sharpest annual moves came in 2023 and 2026: Total Non-Current Liabilities slumped 98.75% in 2023, then surged 21168.07% in 2026.
  • Over 5 years, Total Non-Current Liabilities stood at $115272.5 in 2022, then retreated by 14.04% to $99085.3 in 2023, then decreased by 6.58% to $92564.9 in 2024, then advanced by 2.17% to $94577.0 in 2025, then soared by 112.68% to $201147.0 in 2026.
  • The last three Total Non-Current Liabilities figures came in at $201147.0 (Q3 2026), $94577.0 (Q4 2025), and $945.77 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn 81.11 Bn
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn 36.04 Bn
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn 5.92 Bn
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn 7.74 Bn
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn 3.92 Bn
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn 40.00 Mn
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn 4.20 Bn
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn 12.42 Bn
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn 378.37 Mn
10 Immuron 7.25 Mn -1.77 Mn - 201,147.00
Historic Data

Historic Data

Download Data
DateValue
Aug 28, 2026 201,147.00
Dec 31, 2025 94,577.00
Sep 2, 2025 945.77
Jun 30, 2025 60,570.25
Dec 31, 2024 92,564.94
Sep 9, 2024 943.17
Jun 30, 2024 93,282.28
Dec 31, 2023 99,085.31
Sep 28, 2023 99,768.61
Aug 30, 2023 1,522.07
Jun 30, 2023 101,729.14
Dec 31, 2022 115,272.50
Aug 31, 2022 122,009.86
Jun 30, 2022 125,667.13
Dec 31, 2021 26,496.13
Sep 30, 2021 26,615.86
Jun 30, 2021 27,872.92
Dec 31, 2020 30,581.58
Sep 1, 2020 41,839.00
Jun 30, 2020 27,422.14
API Access

Immuron Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=IMRN&period=max&api_key=YOUR_API_KEY